Precision Medicine approach to Nephrotic Syndrome Anonymous (not verified) Wed, 02/27/2019 - 15:05
NEPTUNE

NEPTUNE has embraced the concept of Precision Medicine proposed by the Institute of Medicine in 2011. The Precision Medicine strategy proposes the development of new disease definitions generated by a multilayered analysis of the disease course while patients receive their usual clinical care in observational studies.

CReATe Consortium initiates biomarker validation study in preparation for clinical trials Anonymous (not verified) Wed, 02/27/2019 - 14:34
CReATe

Through a recently awarded Clinical Trial Readiness grant from NINDS, CReATe investigators are now tapping into the invaluable resource that is the CReATe Biorepository in an effort to clinically validate leading biological fluid-based biomarker candidates to aid the design and implementation of future clinical trials.